HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Triplitt Selected Research

C Triplitt Research Topics

Disease

5Type 2 Diabetes Mellitus (MODY)
11/2021 - 06/2011
5Insulin Resistance
03/2015 - 12/2001
2Weight Gain
03/2015 - 10/2011
2Weight Loss (Weight Reduction)
03/2015 - 10/2011
1Hypoglycemia (Reactive Hypoglycemia)
01/2015
1Hyperglycemia
06/2011
1Inflammation (Inflammations)
05/2011
1Albuminuria
12/2007

Drug/Important Bio-Agent (IBA)

4Glucose (Dextrose)FDA LinkGeneric
03/2015 - 12/2007
3Exenatide (Byetta)FDA Link
11/2021 - 06/2011
2Insulin Glargine (Lantus)FDA Link
11/2021 - 03/2015
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 01/2015
2Pioglitazone (Actos)FDA Link
11/2021 - 03/2015
2Pharmaceutical PreparationsIBA
11/2021 - 03/2015
2Metformin (Glucophage)FDA LinkGeneric
11/2021 - 03/2015
2Insulin (Novolin)FDA Link
06/2011 - 05/2011
2Rosiglitazone (Avandia)FDA Link
12/2007 - 12/2001
2Nonesterified Fatty Acids (NEFA)IBA
12/2007 - 12/2001
1Glipizide (Glucotrol)FDA LinkGeneric
11/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2015
1empagliflozinIBA
01/2015
1LinagliptinIBA
01/2015
15'-palmitoyl cytarabine (PLAC)IBA
10/2011
1muraglitazarIBA
10/2011
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2011
1Biomarkers (Surrogate Marker)IBA
05/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2007
1AdiponectinIBA
12/2007

Therapy/Procedure

4Therapeutics
11/2021 - 05/2011
1Glycemic Control
05/2011